4.3 Article

The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00256.2011

Keywords

basic science; sex hormones; angiotensin receptors

Categories

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia [236821, 490919]
  2. National Heart Foundation of Australia [G06M2640]
  3. Australian Postgraduate Award
  4. NHMRC [490918]

Ask authors/readers for more resources

Sampson AK, Hilliard LM, Moritz KM, Thomas MC, Tikellis C, Widdop RE, Denton KM. The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am J Physiol Regul Integr Comp Physiol 302: R159-R165, 2012. First published October 26, 2011; doi:10.1152/ajpregu.00256.2011.-The complex role of the renin-angiotensin-system (RAS) in arterial pressure regulation has been well documented. Recently, we demonstrated that chronic low-dose angiotensin II (ANG II) infusion decreases arterial pressure in female rats via an AT(2)R-mediated mechanism. Estrogen can differentially regulate components of the RAS and is known to influence arterial pressure regulation. We hypothesized that AT2R-mediated depressor effects evident in females were estrogen dependent and thus would be abolished by ovariectomy and restored by estrogen replacement. Female Sprague-Dawley rats underwent ovariectomy or sham surgery and were treated with 17 beta-estradiol or placebo. Mean arterial pressure (MAP) was measured via telemetry in response to a 2-wk infusion of ANG II (50 ng . kg(-1).min(-1) sc) or saline. MAP significantly decreased in females treated with ANG II (-10 +/- 2 mmHg), a response that was abolished by ovariectomy (+4 +/- 2 mmHg) and restored with estrogen replacement (-6 +/- 2 mmHg). Cardiac and renal gene expression of components of the RAS was differentially regulated by estrogen, such that overall, estrogen shifted the balance of the RAS toward the vasodilatory axis. In conclusion, estrogen-dependent mechanisms offset the vasopressor actions of ANG II by enhancing RAS vasodilator pathways in females. This highlights the potential for these vasodilator pathways as therapeutic targets, particularly in women.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available